Table 1. Clinical characteristics of enrolled papillary thyroid cancer patients.
| NO. | OS | DFS | |||
| Hazard rations (95%CI) | P value | Hazard rations (95%CI) | P value | ||
| Age | |||||
| ≥60 | 92 | 55.284 (7.253–421.414) | 0 | 2.215(1.132–4.336) | 0.02* |
| <60 | 297 | ||||
| Gender | |||||
| Male | 107 | 2.018(0.715–5.698) | 0.185 | 1.285(0.648–2.547) | 0.473 |
| Female | 282 | ||||
| TNM stage | |||||
| Stage I-II | 249 | 9.32(2.621–33.139) | 0.001* | 2.459(1.298–4.658) | 0.006* |
| Stage III-IV | 139 | ||||
| NA | 1 | ||||
| Tumor stage | |||||
| T1-2 | 231 | 3.607(1.147–11.344) | 0.028* | 2.082(1.093–3.967) | 0.026* |
| T3-4 | 156 | ||||
| NA | 2 | ||||
| Lymph node metastasis | |||||
| N0 | 159 | 1.113(0.363–3.41) | 0.852 | 1.824(0.897–3.708) | 0.097 |
| N1 | 204 | ||||
| NA | 26 | ||||
| Distant metastasis | |||||
| M0 | 245 | 8.771(1.846–41.686) | 0.006* | 3.585(0.472–27.246) | 0.217 |
| M1 | 3 | ||||
| NA | 141 | ||||
| Tumor status | |||||
| Tumor free | 309 | 33.189(6.866–160.444) | 0 | 8.287(4.32–15.895) | 0 |
| With tumor | 44 | ||||
| NA | 36 | ||||
NA, not available; CI, confidence interval; *, P<0.05.